On Friday, Shares of Oracle Corporation (NYSE:ORCL), gained 0.09% to $43.81.
Oracle Corporation, declared that its fourth quarter fiscal year 2015 results will be released on Wednesday, June 17th, after the close of the market. Oracle will host a conference call and live webcast at 2:00 p.m. Pacific Time to talk about the financial results.
Oracle Corporation develops, manufactures, markets, hosts, and supports database and middleware software, application software, cloud infrastructure, hardware systems, and related services worldwide.
Shares of ON Semiconductor Corp. (NASDAQ:ON), inclined 0.39% to $12.93, during its last trading session, after the company declared the pricing of its formerly revealed private offering of $600 million aggregate principal amount of 1% convertible senior notes due 2020.
So far recently, 24.29 million shares of ON Semiconductor have exchanged hands as contrast to its average daily volume of 5.14 million shares.
The company has granted initial purchasers of the notes a 30-day option to acquire up to an additional $90 million aggregate principal amount.
The offer is predictable to close on Monday, June 8.
ON Semiconductor Corporation manufactures and sells semiconductor components for various electronic devices worldwide. It operates in four segments: Application Products Group, Image Sensor Group, Standard Products Group, and System Solutions Group.
At the end of Friday’s trade, Shares of Staples, Inc. (NASDAQ:SPLS), lost -0.90% to $16.45.
Staples, declared that it has received clearance from the Commerce Commission of New Zealand to acquire all the outstanding shares of Office Depot, which trades in New Zealand as OfficeMax. Staples continues to work with regulatory agencies in the United States, the European Union, Canada, Australia, and China.
“We’re happy that the Commerce Commission of New Zealand has approved this transaction,” said Ron Sargent, Chairman and Chief Executive Officer, Staples. “We continue to work closely with regulatory agencies around the world and expect the transaction to be accomplished by the end of the year. The combined company will enable Staples to provide more value to customers, and more effectively compete in a rapidly evolving competitive environment.”
Staples, Inc., together with its auxiliaries, operates office products superstores. It operates through three segments: North American Stores & Online, North American Commercial, and International Operations.
Finally, Mast Therapeutics, Inc. (NYSEMKT:MSTX), ended its last trade with 3.52% surge, and closed at $0.53.
Mast Therapeutics, declared that Jack Lief will be resigning from the Company’s Board of Directors. Mr. Lief made this decision to avoid any potential conflict of interest given his role as President and Chief Executive Officer of Arena Pharmaceuticals, Inc. and Arena’s development of a product candidate for the treatment of vascular diseases, counting pulmonary arterial hypertension (PAH). Mast’s, product candidate, AIR001, has been tested in Phase 1 and 2 clinical studies for the treatment of PAH and the Company presently is developing AIR001 for heart failure with preserved ejection fraction (HFpEF).
“I would like to thank Jack for his many important contributions and exceptional service since he joined Mast’s Board in 2006,” stated Brian M. Culley, Chief Executive Officer. “Our Company has greatly benefitted from his leadership as Chair of the Board and his extensive experience in our industry. We appreciate Jack’s willingness to remain on the Board into the third quarter to assist in identifying and evaluating a suitable replacement who can assist guide our company as we approach the end of our Phase 3 EPIC study and plan for commercialization of our lead product candidate, vepoloxamer.”
Mast Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops therapies for serious or life-threatening diseases. The company’s lead product candidate is MST-188 (vepoloxamer), an injection used for the treatment of sickle cell disease, arterial disease, and heart failure.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
